全文获取类型
收费全文 | 5068篇 |
免费 | 263篇 |
国内免费 | 33篇 |
专业分类
耳鼻咽喉 | 53篇 |
儿科学 | 77篇 |
妇产科学 | 76篇 |
基础医学 | 581篇 |
口腔科学 | 110篇 |
临床医学 | 277篇 |
内科学 | 1514篇 |
皮肤病学 | 146篇 |
神经病学 | 380篇 |
特种医学 | 214篇 |
外科学 | 816篇 |
综合类 | 24篇 |
预防医学 | 95篇 |
眼科学 | 98篇 |
药学 | 326篇 |
中国医学 | 27篇 |
肿瘤学 | 550篇 |
出版年
2023年 | 31篇 |
2022年 | 58篇 |
2021年 | 115篇 |
2020年 | 73篇 |
2019年 | 78篇 |
2018年 | 114篇 |
2017年 | 99篇 |
2016年 | 121篇 |
2015年 | 134篇 |
2014年 | 147篇 |
2013年 | 174篇 |
2012年 | 334篇 |
2011年 | 380篇 |
2010年 | 199篇 |
2009年 | 181篇 |
2008年 | 312篇 |
2007年 | 340篇 |
2006年 | 309篇 |
2005年 | 312篇 |
2004年 | 312篇 |
2003年 | 364篇 |
2002年 | 318篇 |
2001年 | 63篇 |
2000年 | 32篇 |
1999年 | 71篇 |
1998年 | 71篇 |
1997年 | 44篇 |
1996年 | 59篇 |
1995年 | 41篇 |
1994年 | 67篇 |
1993年 | 38篇 |
1992年 | 45篇 |
1991年 | 28篇 |
1990年 | 29篇 |
1989年 | 27篇 |
1988年 | 24篇 |
1987年 | 39篇 |
1986年 | 12篇 |
1985年 | 22篇 |
1984年 | 13篇 |
1983年 | 5篇 |
1982年 | 20篇 |
1981年 | 14篇 |
1980年 | 15篇 |
1979年 | 7篇 |
1978年 | 5篇 |
1977年 | 12篇 |
1972年 | 8篇 |
1971年 | 7篇 |
1970年 | 4篇 |
排序方式: 共有5364条查询结果,搜索用时 15 毫秒
61.
Kosuke Nomura Toshiro Iizuka Daisuke Kaji Hisashi Yamamoto Yasutaka Kuribayashi Ryusuke Kimura Akihiro Yamada Tsukasa Furuhata Satoshi Yamashita Daisuke Kikuchi Akira Matsui Toshifumi Mitani Osamu Ogawa Shu Hoteya Yasunori Ota Shuichi Taniguchi Mitsuru Kaise 《Journal of gastroenterology and hepatology》2014,29(11):1867-1872
62.
63.
64.
New therapeutic approach for impaired arteriogenesis in diabetic mouse hindlimb ischemia. 总被引:1,自引:0,他引:1
Shyamal Chandra Bir Masatoshi Fujita Akira Marui Keiichi Hirose Yoshio Arai Hisashi Sakaguchi Yuhong Huang Jiro Esaki Tadashi Ikeda Yasuhiko Tabata Masashi Komeda 《Circulation journal》2008,72(4):633-640
BACKGROUND: The combined treatment of sustained-release basic fibroblast growth factor (Sr-bFGF) and a 5-hydroxytryptamine(2A) blocker, sarpogrelate, was evaluated to see whether it reversed the impaired collateral circulation in diabetic (DM) mouse hindlimb ischemia. METHOD AND RESULTS: Diabetic and normal mice with ischemic hindlimb were randomly assigned to 1 of 5 experimental groups (no treatment, sarpogrelate 50 mg . kg(-1) . day(-1), 20 microg or 50 microg Sr-bFGF and a combined treatment of 20 microg Sr-bFGF and sarpogrelate), and treated for 4 weeks. Tissue blood perfusion (TBP), vascular density (angiogenesis) and the number of mature vessels (arteriogenesis) were checked by the use of standard methods. Although angiogenesis was comparable (161+/-14 vs 154+/-12 vessels/mm(2)), the laser Doppler perfusion image index (LDPII) (0.43+/-0.11 (SD) vs 0.63+/-0.08, p<0.05) and arteriogenesis (8+/-3 vs 12+/-4 vessels/mm(2), p<0.05) were significantly lower in DM mice than those in normal mice. The dose of Sr-bFGF for the sufficient number of mature vessels (>or=45 vessels/mm(2)) and LDPII (>or=0.9) was 20 microg for the normal mice, and 50 microg for the DM mice, which was reduced with the aid of sarpogrelate. Conclusions A combined therapy of Sr-bFGF and sarpogrelate is effective for neovascularization to reverse the impaired arteriogenesis and TBP in DM mice. 相似文献
65.
Cho A Arita S Koike N Isaka N Kusume K Okazumi S Makino H Tohma T Matsubara K Gunji H Ochiai T 《Hepato-gastroenterology》2005,52(66):1886-1888
Two-staged pancreatoduodenectomy, including exteriorization of the pancreatic juice and second-look pancreaticojejunostomy, has been recommended for high-risk patients to avoid pancreatic leakage, which often causes intra-abdominal hemorrhage. We present a new technique of interventional pancreaticojejunostomy under both fluoroscopy and endoscopy without second-look laparotomy. A 77-year-old woman with local recurrence and liver metastasis from colon cancer underwent hepato-pancreatoduodenectomy with the external drainage of pancreatic juice via the pancreatic duct tube without pancreaticojejunostomy. Two months later, the jejunum was punctured with the insertion of a 5-F needle-knife into the pancreatic fistula during endoscopic observation of jejunal lumen, followed by the insertion of two 0.35-inch guidewires into the jejunum and the pancreatic fistula. Finally, a 10-Fr stenting tube was placed between the jejunum and the pancreatic fistula. No complications developed. 相似文献
66.
67.
Shibuya R Suzuki T Miki Y Yoshida K Moriya T Ono K Akahira J Ishida T Hirakawa H Evans DB Sasano H 《Endocrine-related cancer》2008,15(1):113-124
It is well known that sex steroids play important roles in the development of invasive ductal carcinoma (IDC) of the human breast. However, biological significance of sex steroids remains largely unclear in ductal carcinoma in situ (DCIS), regarded as a precursor lesion of IDC, which is partly due to the fact that the intratumoral concentration of sex steroids has not been examined in DCIS. Therefore, in this study, we first examined the intratumoral concentrations of estradiol and 5alpha-dihydrotestosterone (DHT) using liquid chromatography/electrospray tandem mass spectrometry in DCIS. Intratumoral concentrations of both estradiol and DHT were threefold higher in DCIS than non-neoplastic breast tissues and estrogen-producing enzymes (aromatase, steroid sulfatase, and 17beta-hydroxysteroid dehydrogenase type 1 (17betaHSD1)), and androgen-producing enzymes (17betaHSD5 and 5alpha-reductase type 1 (5alphaRed1)) were abundantly expressed in DCIS by real-time PCR and immunohistochemical analyses. The intratumoral concentration of DHT was significantly lower in IDC than DCIS, while the expression of aromatase mRNA in carcinoma cells and intratumoral stromal cells was significantly higher in IDC than those in DCIS. Immunohistochemistry for sex steroid-producing enzymes in DCIS demonstrated that 5alphaRed1 immunoreactivity was positively correlated with Ki-67 labeling index and histological grade and was also associated with an increased risk of recurrence in patients with DCIS examined. Results of our study suggest that intratumoral concentrations of estradiol and DHT are increased in DCIS, which is possibly due to intratumoral production of these steroids. Therefore, estradiol and DHT may play important roles in the development of DCIS of the human breast. 相似文献
68.
Kanetake K Iwata H Mori Y Takagi H Hirota T Nitta T Hayashi M Onitsuka A Hirose H 《Digestion》2003,67(3):170-178
The aim of this study was to analyze which types of T cells are at work and the specific nature of their response, using a mouse 2,4,6-trinitrobenzenesulfonic acid (TNBS) induced colitis model. The response of T cells to TNBS was analyzed by anti-TNBS mixed-lymphocyte reaction. T cell clones were established by limiting dilution. Phenotypes and T cell receptor (TCR) V beta of T cells were analyzed by flow cytometry. Colitis was induced by administration of TNBS enemas, and lamina propria lymphocytes were isolated and analyzed. The proliferative responses to TNBS of spleen T cells were partially inhibited by the addition of antimouse CD4 or CD8 antibodies to the mixed-lymphocyte culture. Conversely, these were inhibited by the addition of both antibodies. Flow cytometric analysis showed that TCR V beta 14 T cells specifically increased in the CD8+ T cell population. We established CD8+ TCR V beta 14 T cell clones which were TNBS reactive and self-restricted. Investigation using lamina propria lymphocytes in TNBS-induced colitis revealed that the rate of CD8+ TCR V beta 14 T cells changed with histological inflammatory activity which also attained a peak on day 5 following enema administration. Both CD4+ and CD8+ T cell subsets responded to TNBS, and the rate of CD8+ TCR V beta 14 T cells changed with histological inflammatory activity in TNBS-induced colitis. 相似文献
69.
Kazuhiro Kitajima Shingo Yamamoto Yusuke Kawanaka Hisashi Komoto Kimihiro Shimatani Takeshi Hanasaki Motohiro Taguchi Seiji Nagasawa Yusuke Yamada Akihiro Kanematsu Koichiro Yamakado 《Medicine》2021,100(23)
This study aimed to evaluate the clinical use of choline-PET/CT for discriminating viable progressive osteoblastic bone metastasis from benign osteoblastic change induced by the treatment effect and evaluating the response of bone metastasis to treatment in metastatic castration-resistant prostate cancer (mCRPC) patients. Thirty patients with mCRPC underwent a total of 56 11C-choline-PET/CT scans for restaging, because 4 patients received 1 scan and 26 had 2 scans. Using 2 (pre- and post-treatment) 11C-choline-PET/CT examinations per patient, treatment response was assessed according to European Organization for Research and Treatment of Cancer (EORTC) criteria in 20 situations, in which only bony metastases were observed on 11C-choline-PET/CT scans. Viable bone metastases and osteoblastic change induced by the treatment effect were identified in 53 (94.6%) and 29 (51.8%) of 56 11C-choline-PET/CT scans, respectively. In 27 cases (48.2%), 11C-choline-PET/CT scans could discriminate the 2 entities. The mean SUVmax of the metastatic bony lesions was 5.82 ± 3.21, 5.95 ± 3.96, 6.73 ± 5.04, and 7.91 ± 3.25 for the osteoblastic, osteolytic, mixed, and invisible types, respectively. Of the 20 situations analyzed, CMR, PMR, SMD, and PMD, as determined by the EORTC, were seen in 1, 2, 3, and 14 cases, respectively. Of the 13 patients with increasing PSA trend, all 13 showed PMD. Of the 2 patients with PSA response of <50%, both 2 showed SMD. Of the 5 patients with PSA response of ≥50%, 1 showed CMR, 2 showed PMR, 1 showed SMD, and 1 showed PMD. Choline-PET/CT is very useful to discriminate viable progressive osteoblastic bone metastasis from osteoblastic change, and assess treatment response of bone metastases in mCRPC. 相似文献
70.
Furuya Takefumi Oh Koei Ikari Katsunori Inoue Eisuke Tanaka Eiichi Yamanaka Hisashi Harigai Masayoshi 《Clinical rheumatology》2022,41(2):405-410
Clinical Rheumatology - This study aimed to evaluate the prevalence of, and the factors associated with, frailty in Japanese patients with rheumatoid arthritis (RA). Patients with RA enrolled in... 相似文献